Introduction
============

The zinc-finger antiviral protein (ZAP) was originally identified from a rat cDNA library due to its conferring resistance to murine leukemia viruses ([@bib28]). Subsequent studies indicated that ZAP also inhibits several viruses of the alphaviridae ([@bib6]; [@bib92]) and filoviridae ([@bib53]) families. ZAP acts through direct binding to the viral RNA and recruits the processing exosome, eventually leading to viral RNA degradation ([@bib38], [@bib39]).

The human ortholog of ZAP is encoded by *ZC3HAV1*, an interferon-inducible gene located on chromosome 7 (7q34). The gene codes for two major isoforms generated by alternative splicing ([@bib43]). The products share a common N-terminus carrying four CCCH zinc-finger motifs, although only the longest isoform displays a carboxy-terminal poly(ADP-ribose) polymerase (PARP)--like domain. The CCCH zinc-finger motifs are directly involved in viral RNA binding; conversely, the precise function of the PARP-like domain is unknown, but it enhances the activity of ZC3HAV1 against alphaviruses ([@bib43]).

A recent evolutionary study in primates indicated that the PARP-like domain, but not the CCCH zinc-finger domains, has been subjected to recurrent episodes of positive selection ([@bib43]). These data, albeit unexpected given the role of the N-terminal zinc fingers in viral recognition ([@bib38]), are consistent with the notion whereby genes involved in immune response have been common targets of natural selection along primate and mammalian history ([@bib4]).

Viruses have exerted a selective pressure on several human genes, and a certain degree of overlap has been noticed between genes targeted by virus-driven selective pressure and loci involved in the pathogenesis of autoimmune diseases including multiple sclerosis (MS) ([@bib25]), a demyelinating autoimmune disease of the central nervous system. This parallelism and the observation that a subset of alleles for such diseases represent selection targets ([@bib26]; [@bib4]) contribute to a long-term debate concerning the underlying selective patterns and pressures responsible for the maintenance of autoimmune susceptibility variants in human populations ([@bib4]; [@bib72]).

Here, we analyzed the selective pattern of the *ZC3HAV1* PARP-like domain in human populations and in *Pan troglodytes*. Our data indicate that long-term balancing selection has maintained a human/chimpanzee *trans*-specific Thr/Ile polymorphism in *ZC3HAV1*, and this variant is associated with higher risk of MS in Italian populations.

Materials and Methods
=====================

Samples and Sequencing
----------------------

Human genomic DNA from HapMap subjects (20 Yoruba, YRI, 20 European, CEU, and 20 Asians, AS; 24 and 15 African American, AA, and South American, SAI individuals, respectively) was obtained from the Coriell Institute for Medical Research. All analyzed regions were polymerase chain reaction (PCR) amplified and directly sequenced. PCR products were treated with ExoSAP-IT (USB Corporation, Cleveland OH), directly sequenced on both strands with a Big Dye Terminator sequencing Kit (v3.1 Applied Biosystems) and run on an Applied Biosystems ABI 3130 XL Genetic Analyzer (Applied Biosystems). Sequences were assembled using AutoAssembler version 1.4.0 (Applied Biosystems) and inspected manually by two distinct operators. The genomic DNA of 9 *P.troglodytes* was obtained from the Gene Bank of Primates, Primate Genetics, Germany (<http://dpz.eu/index.php>).

Chimpanzee subspecies was determined by the analysis of mitochondrial DNA (mtDNA) and Y chromosome as described ([@bib75]) as well as by application of STRUCTURE analysis ([@bib61]) to resequenced autosomal regions. In particular, the mtDNA hypervariable region I was sequenced for all individuals using previously described primer pairs ([@bib52]) and compared with published sequences ([@bib52]) to infer the maternal origin of each individual. Three regions (sY19, sY84, and sY123) on the nonrecombining portion of the Y chromosome ([@bib75]) were also sequenced for the three male chimpanzee individuals in our sample and compared with previous data from *P.troglodytes* subspecies ([@bib75]). Since the paternal origin of the six females in our sample could not be determined, we used data from 26 autosomal biallelic markers for STRUCTURE analysis ([@bib61]). In particular, one SNP was randomly selected for each of the chromosomal genomic regions we resequenced in *P.troglodytes* (*n* = 16)*.* Ten additional variants were included and derived from genotyping of these same individuals at ten genes (one SNP per gene in *PTPN22*, *CD4*, *IFIH1*, *LY9*, *AICDA*, *PON1*, *OAS1*, *SFTPD*, *CTLA4*, and *PIAS1*), which we are currently analyzing in this species (manuscript in preparation)*.* STRUCTURE was used in the "admixture" mode so that individuals are allowed to have ancestry from multiple populations. We used a model of correlated allele frequencies with 100,000 burn-in iterations and 1,000,000 follow-on Markov chain Monte Carlo iterations. The program was run 20 times for each value of *K* ranging from 1 to 4, and for each run, the posterior probability of *K* = 1, 2, 3, or 4 was calculated. Results of these runs indicated that a model with *K* = 1 has much higher probability compared with the other values of *K* ([supplementary fig. S1](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online).

All chimpanzee gene regions were resequenced as described above. All primers used in the study are available as [supplementary table S1](#sup1){ref-type="supplementary-material"} ([Supplementary Material](#sup1){ref-type="supplementary-material"} online).

Case/Control Association Study
------------------------------

The case/control population from mainland Italy comprised 507 patients (333 females and 174 males) and 523 age- and sex-matched healthy individuals (333 females and 190 males) with the same geographic origin. MS patients were recruited at the MS Centre of Don Gnocchi Foundation in Milan and at Department of Neurological Sciences, University of Milan. All patients gave informed consent according to protocols approved by the local Ethics Committees. All patients and controls were Italian of European ancestry. Patients underwent a standard battery of examinations, including medical history, physical and neurological examination, screening laboratory test, brain magnetic resonance imaging. All MS subjects fulfilled McDonald\'s criteria ([@bib49]). Median age was 40.5 (standard deviation \[SD\]: 11.1) and 42.2 (SD: 20.5) years for MS and controls, respectively. Genotyping of rs3735007 was performed by direct resequencing, as described above, using genomic DNA extracted from peripheral blood.

The case/control populations from Sardinia consist of 2,273 patients and 1,917 healthy individuals recruited from all over the island and for whom at least three of the four grandparents were of Sardinian origin ([@bib70]). Patients were all of the relapsing--remitting form of MS, and they have been diagnosed and selected using the McDonald criteria ([@bib49]). The female to male ratio was equal to 2.1:1 in the assessed samples. The control group of healthy individuals is composed of 1,917 adult volunteer blood donors, unrelated to each other and to the patients and also 231 affected family-based controls (AFBAC) derived from 231 MS family trios. AFBAC allele and haplotype frequencies are constructed using the two alleles in each trio that are not transmitted from the parents to the affected child. These familial pseudocontrols are matched to the cases for ethnic origin and are thus robust to population stratification ([@bib80]). All individuals studied and all analyses on their samples were done according to the Declaration of Helsinki and were approved by the local medical ethics and institutional review committees. Individuals were genotyped using the Affymetrix 6.0 array, and standard quality control filters were applied (single nucleotide polymorphism \[SNP\] call rate \> 98%, Hardy--Weinberg equilibrium, HWE~*P*\ value~ \> 10^−6^, minor allele frequency \> 1%, lack of excess of Mendelian errors or discrepancies in genotyped trios or DNA duplicates) ([@bib70]). Among the genotyped and quality control assessed SNPs, rs1047129 marker showed the highest linkage disequilibrium (LD) with rs3735007 and was used for replication. At this variant, genotypes were successfully called for 2,271 patients, 1,915 controls and were unambiguously determined for 231 AFBAC.

As for the Belgian sample, patients of European descent fulfilled Poser or McDonald criteria ([@bib49]; [@bib60]) for the diagnosis of MS and were compared with controls from the same population. All individuals gave appropriate informed consent, and the study was approved by the Ethics Committee of the University Hospitals Leuven. Genotyping of rs3735007 was performed using a Taqman Assay-on-Demand on a 7300 Sequence Detection System (Applied Biosystems) according to the manufacturer\'s instructions.

Compliance to HWE was evaluated by a *χ*^2^ test. The association of SNP genotypes with disease was calculated using PLINK ([@bib64]).

The Wittke-Thompson test for HWE deviation was performed as described by the authors ([@bib88]). Equations are parametrized in *q* (susceptibility allele frequency), *α* (risk in nonsusceptible homozygotes), *β* (heterozygote relative risk), *γ* (homozygote relative risk), and *K*~p~ (trait prevalence in the general population). We obtained maximum likelihood (ML) estimates for these parameters minimizing the goodness-of-fit test statistic (as reported in [@bib88]) using the Broyden-Fletcher-Goldfarb-Shanno method. Using an estimate of *K*~p~, the procedure was repeated with a general model estimating *q*, *β*, and *γ*, and for constrained specific models, estimating *q* and gamma (dominant: beta = *γ*; recessive: *β* = 1, *γ* \> 1; additive: *β* = (*γ* + 1)/2, *γ* \> 1; and multiplicative: *β* = sqrt(*γ*), *γ* \> 1). Given the different number of parameters in the general model, the Akaike information criteria were used for the best-fit model selection. A *P* value was then calculated for the minimal value of the test statistic using a *χ*^2^ distribution with 1 or 2 degrees of freedom (df) for the general and constrained models, respectively.

Calculations were carried out in the R environment ([@bib65]).

Population Genetic Analyses
---------------------------

Tajima\'s *D* (*D*~T~) ([@bib77]), Fu and Li\'s *D*\* and *F*\* ([@bib23]) statistics as well as diversity parameters *θ*~W~ ([@bib87]) and *π* ([@bib55]) were calculated using libsequence ([@bib82]). Calibrated coalescent simulations were performed using the cosi package ([@bib71]) and its best-fit parameters for YRI, AA, CEU, and AS populations with 10,000 iterations. For SAI, a previously reported demographic model ([@bib67]) was used and included in the cosi best-fit model. Demographic parameters for YRI, AA, CEU, and AS implemented in cosi are described in [@bib71]. Coalescent simulation was also run using additional demographic models ([@bib47]; [@bib86]; [@bib40]). In all cases, they were conditioned on mutation and recombination rates. Estimates of the population recombination rate parameter *ρ* were obtained from resequencing data with the use of the Web application MAXDIP (<http://genapps.uchicago.edu/maxdip/>) ([@bib41]) and converted in centimorgan per megabase. The lower recombination rate obtained from the five populations in each region was used in coalescent simulations; these amounted to 0.31 cM/Mb for ZC3HAV1 exons 10--12 and 0.0025 cM/Mb for the region covering exon 13. *P* values of summary statistics for the analyzed ZC3HAV1 regions were obtained by comparing the observed *D*~T~, *D*\* and *F*\* with the distribution in the 10,000 simulated genealogies.

The ML-ratio HKA test was performed using the MLHKA software ([@bib90]), as previously proposed ([@bib24]). For human populations, 16 reference loci were randomly selected among loci included in the National Institute of Environmental Health Sciences (NIEHS) Genome Project, that are shorter than 20 kb and that have been resequenced in the four populations; the only criterion was that Tajima\'s *D* values were consistent with neutrality (i.e., Tajima\'s *D* is higher than the fifth and lower than the 95th percentiles in the distribution of NIEHS genes). As for chimpanzee, the MLHKA was performed using the 16 resequenced regions as reference loci.

Genotype data for 2 kb regions from 238 resequenced human genes were derived from the NIEHS SNPs Program web site (<http://egp.gs.washington.edu>). In particular, we selected genes that had been resequenced in populations of defined ethnicity including Europeans, Yoruba, African American, and Asians (NIEHS panel 2). Similarly, genotype data for 5-kb windows were obtained from the NIEHS Program web site; in this case, windows were randomly selected with the only requirement that they contain at least five segregating sites in all analyzed populations.

Data from the Pilot 1 phase of the 1000 Genomes Project were retrieved from the dedicated web site (<http://www.1000genomes.org/>). Low-coverage SNP genotypes were organized in a MySQL database. A set of programs was developed to retrieve genotypes from the database and to analyze them according to selected regions/populations. These programs were developed in C++ using the GeCo++ ([@bib13]) and the libsequence ([@bib82]) libraries. Genotype information was obtained for *ZC3HAV1* and for 2,000 randomly selected RefSeq genes.

Sliding-window analysis was performed on overlapping 2.5-kb windows moving with a step of 250 bp. For each window, we calculated *θ*~W~ divided by the total number of fixed differences and *π*. As for site frequency spectrum--based statistics, these were calculated using low-coverage data for the two *ZC3HAV1* gene regions and for 2,000 windows randomly derived from the genes mentioned above. These windows were 2 kb in size and were used to obtain the distribution of *D*~T~, *F*\* and *D*\* in the three human populations. Masking of transposable elements was performed through University of California--San Cruz annotation tables (Repeating Elements by RepeatMasker track).

For the comparison of nucleotide diversity estimates derived from Sanger resequencing and low-coverage whole-genome data, we analyzed all genes included in the NIEHS panel 2 (*n* = 238). Fully resequenced (i.e., without resequencing gaps) genic regions were identified and divided into continuous subregions depending on their annotation in the NIEHS data as unique DNA or transposable elements. This procedure yielded a total of 5,271 unique regions (average size = 659 bp) and 5,192 repetitive regions (average size = 249 bp). *θ*~W~ was calculated as described above for YRI, CEU, and AS using both NIEHS and 1000 Genomes sequencing data. Correlations between nucleotide diversity estimates were calculated using Kendall\'s correlation coefficients (*τ*), a nonparametric statistic used to measure the degree of correspondence between two rankings. The reason for using this test is that even in the presence of ties, the sampling distribution of *τ* satisfactorily converges to a normal distribution for values of *n* larger than 10 ([@bib69]). A normal approximation with continuity correction to account for ties was used for *P* value calculations ([@bib42]).

Haplotype Analysis and Time to the Most Recent Common Ancestor Calculation
--------------------------------------------------------------------------

Haplotypes were inferred using PHASE version 2.1 ([@bib74]; [@bib73]). In order to check for consistency, 100, 250, and 500 iterations were performed with the last runs ten times longer than other runs (-X10 flag) to increase estimate accuracy. Haplotypes for individuals resequenced in this study are available as [supplementary table S2](#sup1){ref-type="supplementary-material"} ([Supplementary Material](#sup1){ref-type="supplementary-material"} online). LD analyses were performed using the Haploview (v. 4.1) ([@bib5]) using SNP data from HapMap and default parameters (HWE~*P*\ value~ cutoff = 0.001, minimum genotype percentage = 75%, maximum number of Mendel errors = 1, minor minimum allele frequency = 0.001). Haplotype blocks were identified through the confidence interval method ([@bib27]). The significance of LD was assessed by means of a standard chi-square statistic as implemented in graphical overview of linkage disequilibrium (GOLD) ([@bib1]) and Bonferroni corrected for the number of tested SNP pairs. GOLD groups low-frequency alleles to avoid spurious results: We used the default grouping strategy at 7%. An additional analysis of recombination was performed using the LDhat program ([@bib51]), which uses the composite likelihood method of Hudson ([@bib41]), extended to finite-sites models, to calculate the population recombination rate *ρ* (4*N*~e~*r*) given an estimate of *θ*~W~. The program then uses a likelihood permutation test to address the presence of recombination and identifies SNP pairs that display more or less LD than expected assuming a constant recombination rate over the entire region. Rare variants (i.e., with minor allele frequency lower than 5%) are omitted from the analysis as uninformative.

Median-joining networks to infer haplotype genealogy were constructed using NETWORK 4.5 ([@bib3]). Estimate of the time to the most common ancestor (TMRCA) was obtained using a phylogeny-based approach implemented in NETWORK 4.5 using a mutation rate based on the number of fixed differences between chimpanzee and humans. An additional TMRCA estimate derived from application of a ML coalescent method implemented in GENETREE ([@bib36], [@bib37]). The method assumes an infinite-site model without recombination; therefore, haplotypes and sites that violate these assumptions need to be removed: In the case of ZC3HAV1, we eliminated three variants. Again, the mutation rate *μ* was obtained on the basis of the divergence between human and chimpanzee and under the assumption both that the species separation occurred 6 Ma ([@bib32]) and of a generation time of 25 years. The migration matrix was derived from previous estimated migration rates ([@bib71]). Using *μ* and *θ* maximum likelihood (*θ*~ML~), we estimated the effective population size parameter (*N*~e~); this result equaled 22,400. With these assumptions, the coalescence time, scaled in 2*N*~e~ units, was converted into years. For the coalescence process, 10^6^ simulations were performed. A third TMRCA estimate was obtained by applying a previously described method ([@bib21]) that calculates the average pairwise difference between all chromosomes and the MRCA: This value was converted into years on the basis of mutation rate retrieved as above. The SD for this estimate was calculated as previously described ([@bib81]).

Prediction of SNP Effect
------------------------

Genomic evolutionary rate profiling (GERP) and Grantham scores for rs3735007 were obtained from the NIEHS Exome Variant Server (<http://snp.gs.washington.edu/niehsExome/>). Prediction of SNP effects using PolyPhen ([@bib76]), PolyPhen2 ([@bib2]), SIFT ([@bib57]), Panther ([@bib79]), SNPs&GO ([@bib12]), SNAP ([@bib7]), and MutPred ([@bib46]) were obtained from the dedicated websites: <http://blocks.fhcrc.org/sift/SIFT.html>, <http://genetics.bwh.harvard.edu/pph/>, <http://genetics.bwh.harvard.edu/pph2/>, <http://www.pantherdb.org/tools/csnpScoreForm.jsp>, <http://snps-and-go.biocomp.unibo.it/snps-and-go>, <http://www.rostlab.org/services/SNAP>, <http://mutpred.mutdb.org>. Prediction of protein ubiquitination probabilities was calculated using the UbPRED (<http://www.ubpred.org>) and CKSAAP_UbSite (<http://protein.cau.edu.cn/cksaap_ubsite/index.php>) servers.

Results
=======

Nucleotide Diversity and Neutrality Tests in Human Populations
--------------------------------------------------------------

The PARP-like domain of *ZC3HAV1* is encoded by exons 10--13 ([@bib43]). The region covering these exons is in relatively tight LD in most human populations ([fig. 1](#fig1){ref-type="fig"} and [supplementary fig. S2](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online); indeed, LD extends beyond exon 13 and also covers part of the nearby *ZC3HAV1L* gene. ([supplementary fig. S2](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). In order to analyze the evolutionary history of the PARP-like domain, we resequenced two distinct genomic regions covering exons 10--12 (region 1, 2.40 kb) and 13 (region 2, 2.05 kb) ([fig. 1](#fig1){ref-type="fig"}) in five human populations (Yoruba, YRI; African Americans, AA; Europeans, CEU; East Asians, AS; and South Americans, SAI). The number of segregating variants identified in each human population for the two regions is reported in [table 1](#tbl1){ref-type="table"}. The statistical significance of LD between SNP pairs was evaluated using these data and indicated stronger LD in the region encompassing exon 13 ([supplementary fig. S3](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). An additional analysis of recombination in the two regions was performed using a composite likelihood method implemented in LDhat ([@bib51]). In both regions and for the five populations analyzed separately, values of *ρ* equal or very close to 0 were obtained, and the likelihood permutation test revealed no evidence of recombination. No SNP pair in either region displayed significantly higher or lower LD than expected given the SNP frequencies and the estimate of *ρ* ∼ 0.

###### 

Nucleotide Diversity and Neutrality Tests for the *ZC3HAV1* Gene Regions.

                                     θ~W~ (×10^−4^)   Π (×10^−4^)   Tajima\'s *D*   Fu and Li\'s *D*\*   Fu and Li\'s *F*\*   Fu and Li\'s *D*   Fu and Li\'s *F*                                                       
  ------------------ ----- ---- ---- ---------------- ------------- --------------- -------------------- -------------------- ------------------ ------------------ -------- ---------------- -------- ---------------- ----------------
  1 (exons 10--12)   YRI   40   11   10.77            0.77          14.93           0.39                 1.17 (0.025)         0.96               0.35 (0.2)         0.70     0.73 (0.081)     0.84     0.22 (0.25)      0.60 (0.11)
                     AA    48   13   12.20            0.81          16.18           0.47                 0.99 (0.035)         0.94               −0.51 (0.53)       0.40     −0.012 (0.28)    0.62     −0.17 (0.38)     −0.20 (0.21)
                     CEU   40   12   11.75            0.93          15.20           0.59                 0.91 (0.18)          0.80               0.97 (0.14)        0.83     1.11 (0.12)      0.87     0.93 (0.15)      1.00 (0.16)
                     AS    40   11   10.77            0.93          10.75           0.44                 −0.0047 (0.47)       0.51               −1.28 (0.14)       0.19     −1.02 (0.19)     0.27     −0.41 (0.35)     −0.40 (0.35)
                     SAI   30   8    8.41             n.a.          12.62           n.a.                 1.52 (0.086)         n.a.               0.056 (0.51)       n.a.     0.59 (0.32)      n.a.     1.33 (0.066)     1.570 (0.059)
  2 (exon 13)        YRI   40   19   21.77            0.98          40.20           0.95                 2.78 (\<0.001)       \>0.99             1.65 (\<0.001)     \>0.99   2.39 (\<0.001)   \>0.99   1.79 (\<0.001)   2.58 (\<0.001)
                     AA    48   22   24.16            0.99          41.35           0.95                 2.31 (0.0011)        \>0.99             0.70 (0.12)        0.86     1.49 (0.01)      0.99     1.11 (0.057)     1.87 (0.003)
                     CEU   40   18   20.62            0.98          39.33           0.95                 2.96 (\<0.0012)      \>0.99             1.25 (0.057)       0.95     2.15 (0.002)     \>0.99   1.35 (0.04)      2.30 (0.002)
                     AS    40   17   19.48            0.99          38.63           0.94                 3.19 (\<0.0014)      0.99               1.21 (0.06)        0.95     2.21 (0.0025)    0.99     1.30 (0.04)      2.35 (0.002)
                     SAI   30   16   19.68            n.a.          10.04           n.a.                 −1.66 (0.29)         n.a.               1.56 (\<0.001)     n.a.     0.64 (0.32)      n.a.     1.71 (\<0.001)   0.70 (0.30)

N[OTE]{.smallcaps}.---n.a., not available.

Sample size (chromosomes).

Number of segregating sites.

Percentile rank relative to a distribution of 2 kb windows from NIEHS genes.

*P* value calculated by coalescent simulations.

![Schematic diagram of the exon--intron structure of *ZC3HAV1*. Exons are indicated with the gray boxes. The two regions we resequenced are denoted by the hatched lines. The LD (*r^2^*) plot refers to CEU, and data were derived from HapMap. The two *trans*-specific SNPs are shown.](molbiolevolmss002f01_ht){#fig1}

We calculated nucleotide diversity by means of *θ*~W~ ([@bib87]) and *π* ([@bib55]) for the two regions we resequenced in *ZC3HAV1* and for a large number of windows 2 kb in size (see Materials and Methods) deriving from 238 human genes resequenced by the NIEHS SNP Discovery Program (<http://egp.gs.washington.edu/>) in CEU, AA, YRI, and AS (data for SAI are not available). The empirical distributions obtained from these windows were used to calculate the percentile rank of *θ*~W~ and *π* values for the *ZC3HAV1* regions. As shown in [table 1](#tbl1){ref-type="table"}, no exceptional diversity was observed for exons 10--12; conversely, extremely high values for both *θ*~W~ and *π* were observed for the region covering exon 13 in all populations. Randomly selected 2-kb windows may contain few segregating sites, possibly introducing a large variance in the distribution of diversity values. Thus, we also performed the same calculations using 5-kb windows sampled from the same genes; very similar results were obtained in these analyses ([supplementary table S3](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online).

Polymorphism levels also depend on local mutation rates; therefore, under neutral evolution, the amount of within- and between-species diversity is expected to be similar at all loci in the genome. The multilocus HKA test was developed to verify this expectation ([@bib90]). Specifically, we applied a multilocus MLHKA (maximum likelihood HKA) test by comparing polymorphism and divergence levels at the *ZC3HAV1* regions with 16 NIEHS genes resequenced in YRI, AA, CEU, and AS. As specified in the Materials and Methods, these genes were randomly selected among NIEHS loci shorter than 20 kb that showed no evidence of natural selection ([@bib24]). No significant excess of intra- versus interspecies diversity was observed for region 1 ([table 2](#tbl2){ref-type="table"}). Conversely, *ZC3HAV1* region 2 displays a significant excess of polymorphism compared with divergence in all populations ([table 2](#tbl2){ref-type="table"}). It is worth noting that *ZC3HAV1* is located on chromosome 7 in tandem orientation with a homolog, *ZC3HAVL1*. Yet, this latter displays no PARP-like domain and, therefore, no alignment with *ZC3HAV1* across exons 10--13. Thus, conversion events between the two genes are not expected to occur in the region we analyzed.

###### 

MLHKA Test for the Two Analyzed *ZC3HAV1* Regions.

           MLHKA                                                  
  --- ---- ------- ------- ------ -------- ------ -------- ------ --------
  1   21   2.06    0.28    2.74   0.053    2.38   0.069    2.17   0.17
  2   15   3.15    0.012   3.94   0.0019   4.07   0.0012   5.29   0.0004

Number of fixed substitutions (human/chimpanzee).

Selection parameter (*k* \> 1 indicates an excess of polymorphism relative to divergence).

Unusually, high levels of genetic diversity might indicate the action of balancing selection, as neutral variation tends to be maintained with the selected alleles. Another hallmark of balancing selection is a distortion of the SFS toward intermediate frequency alleles. Thus, to gain further insight into the evolutionary history of the two *ZC3HAV1* regions, we applied SFS-based tests, such as Tajima\'s *D* (*D*~T~) ([@bib77]) and Fu and Li\'s *D*\* and *F*\* ([@bib23]). We evaluated the statistical significance *D*~T~, *D*\* and *F*\* by means both of coalescent simulations that incorporate demographic scenarios (see Material and Methods) and of empirical comparison with the distribution of these statistics calculated over 2-kb windows. Most statistics failed to reject the null hypothesis of selective neutrality for the *ZC3HAV1* region 1 ([table 1](#tbl1){ref-type="table"}). Conversely, SFS-based statistics calculated for region 2 yielded significantly high values both in coalescent simulations and empirical comparisons for YRI, CEU, and AS. As for SAI, coalescent simulations yielded a significantly low value for *D*~T~ and a significantly high result for *D*\*. Very similar results were obtained with SFS-based statistics that incorporate out-group information (from orangutan in this case), namely Fu and Li\'s *F* and *D*, whose statistical significance was calculated through coalescent simulations ([table 1](#tbl1){ref-type="table"}). Comparable percentile ranks were also obtained using the distribution of 5-kb reference windows ([supplementary table S3](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online) and by applying different demographic scenarios in coalescent simulations (see Materials and Methods) ([supplementary table S4](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online).

Overall, these data suggest that balancing selection has been acting on *ZC3HAV1* exon 13.

Identification of *Trans*-Specific Polymorphisms and Population Genetic Analysis in Chimpanzees
-----------------------------------------------------------------------------------------------

In order to analyze the evolutionary history of the *ZC3HAV1* exon 13 region in chimpanzee and to assess the presence of *trans*-specific polymorphisms, we resequenced nine *P.troglodytes* individuals.

A total of nine segregating sites were identified, two of them being shared with humans. Although one of these SNPs (rs10250435) occurs at a CpG dinucleotide, suggesting that it may be accounted for by independent mutations arisen after speciation, rs3735007 (C/T) does not involve a CpG and represents a nonsynonymous substitution (Thr851Ile). The probability of observing *n* shared SNPs in a genomic region where segregating sites are observed in two species is given by the hypergeomtric density ([@bib16]). Nineteen and 6 non-CpG SNPs segregate in humans and chimpanzees, respectively, in the *ZC3HAV1* resequenced region. Thus, the probability of observing one polymorphism at the same position over a length of 1,969 non-CpG nucleotides amounts to 0.055; given that roughly 2/3 of substitutions are accounted for by transitions in humans ([@bib54]), the probability of observing the same alleles in the two species amounts to ∼0.036 for transitions (which is the case of rs3735007). The same calculation can be performed for SNPs that occur at CpG dinucleotides (five and three in humans and chimpanzees, respectively): In this case, by considering 66 CpG dinucleotides in the human/chimpanzee ancestor, the probability of observing a shared polymorphism involving a CpG amounts to 0.199; among substitutions at CpGs, roughly 75% are transitions ([@bib54]), resulting in a probability of 0.15 to observe the same alleles in the two species at the same CpG site. Thus, the combined probability that the two *trans*-specific polymorphisms have occurred independently in the two lineages is low (*P* = 0.0054).

The presence of human--chimpanzee *trans*-specific polymorphisms *s*uggests that balancing selection signatures should be detectable in *P.troglodytes* populations, as well. To test this possibility, we performed population genetic analyses in this species. Since we had no information concerning the geographic origin and subspecies type of these individuals, we addressed this issue first. Analysis of mtDNA indicated that all of them had *P.t. verus* maternal origin; similarly, the three male chimpanzees had Y chromosomes suggesting *P.t. verus* paternal ancestry. STRUCTURE analysis of these individuals using 26 autosomal loci (see Materials and Methods) indicated that a model with only one cluster (*k* = 1) had much higher probability compared to models with *K* = 2, 3, or 4 ([supplementary fig. S1](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online), suggesting that all individuals belong to the same subspecies (i.e., *P.t. verus*). In order to assess whether *ZC3HAV1* shows unusual levels of nucleotide variability, we resequenced 16 genomic regions in these same individuals to be used as an empirical comparison. All regions were similar in size to *ZC3HAV1* region 2 and are described in the [supplementary table S5](#sup1){ref-type="supplementary-material"} ([Supplementary Material](#sup1){ref-type="supplementary-material"} online). Ten of these regions were intergenic and previously proposed to be neutrally evolving ([@bib22]); six more intergenic regions were randomly selected with the only requirement that no gene was annotated within 200 kb. Calculation of *θ*~W~ and *π* indicated that region 2 in *ZC3HAV1* shows the highest values of diversity compared with the 16 reference regions ([fig. 2](#fig2){ref-type="fig"}). This result was confirmed by application of the MLHKA test, which yielded significant results (*k* = 2.95, *P* = 0.049). Conversely, SFS-based statistics (*D*~T~, *F*\* and *D*\*) were not exceptionally high in this region ([supplementary table S5](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). In order to analyze the haplotype genealogy for the *ZC3HAV1* region 2 in chimpanzees, we constructed a median-joining network; this indicated the presence of two major clades, with one basal branch carrying the *trans*-specific polymorphism ([fig. 2](#fig2){ref-type="fig"}). Haplotype frequency in our *P. troglodytes* sample was very different between the two clades, resulting in no excess of intermediate frequency alleles. This explains the failure of SFS-based tests to reject neutrality.

![Nucleotide diversity and haplotype analysis in chimpanzee. (*A*) Plot of *θ*~W~ and *π* values for the 16 regions we analyzed (white circles) and for *ZC3HAV1* region 2 (black). (*B*) Network analysis of region 2 in chimpanzee: the MRCA is indicated by the black circle; the position of the *trans*-specific variant is shown (arrow).](molbiolevolmss002f02_ht){#fig2}

Haplotype Genealogy and Estimation of the TMRCA
-----------------------------------------------

In analogy to the analysis we performed in chimpanzees, we analyzed the genealogy of human haplotypes identified in the five populations. The topology of the median-joining network displays two major clades (denoted as 1 and 2 in [fig. 3](#fig3){ref-type="fig"}) containing common haplotypes and separated by long-branch lengths. The Thr851Ile polymorphism (variant 4 in the network) defines the major haplotype in clade 1 ([fig. 3](#fig3){ref-type="fig"}). All populations tend to display a similar frequency of haplotypes in the two clades with the exception of SAI chromosomes that mainly cluster in clade 1. This observation explains the low value of *D*~T~ we obtained for this population ([table 1](#tbl1){ref-type="table"}).

![Median-joining network and GENETREE analysis of *ZC3HAV1* haplotypes. (*A*) Median-joining network: each node represents a different haplotype, with the size of the circle proportional to frequency. Nucleotide differences between haplotypes are indicated on the branches of the network. Circles are color coded according to population (green: YRI, yellow: AA, blue: CEU, red: AS, and orange: SAI). The MRCA is also shown (black circle). The relative position of mutations along a branch is arbitrary. (*B*) GENETREE: mutations are represented as black dots and named for their physical position along the regions. The absolute frequency of each haplotype is also reported. Note that mutation numbering does not correspond to that reported in (*A*) (see Materials and Methods).](molbiolevolmss002f03_3c){#fig3}

In line with the relatively tight LD in the region, the network displayed no reticulation, and only a couple of recurrent mutations occur in the genealogy. Under these conditions, estimation of the TMRCA is robust. To this aim, we applied three approaches; the first is a phylogeny-based method that calculates the average pairwise difference between the haplotype clusters and a root ([@bib3]). Using a mutation rate based on the number of fixed differences with chimpanzee and a separation time of 6 myr ([@bib32]), we estimated TMRCAs of 5.96 myr (SD: 1.42 myr). The second approach is implemented in GENETREE and is based on an ML coalescent analysis ([@bib36], [@bib37]). Using this method, the TMRCA of the *ZC3HAV1* haplotype lineages amounted to 4.36 myr (SD: 1.05 myr) ([fig. 3](#fig3){ref-type="fig"}). A third TMRCA of 6.12 myr (SD: 2.2 myr) was obtained by the application of a previously proposed method based on the mean nucleotide diversity between all chromosomes and an MRCA ([@bib21]).

These TMRCA estimates are much deeper than expected under neutrality ([@bib83]; [@bib29]).

Sliding-Window Analysis with 1000 Genomes Pilot Project Data
------------------------------------------------------------

Due to the combined action of mutation and recombination, signatures of long-standing balancing selection are expected to extend over relatively short genomic regions ([@bib14]). We took advantage of the availability of data from the 1000 Genomes Pilot project ([@bib30]) to verify this expectation by analyzing sequence variation along the entire *ZC3HAV1* transcription unit. The low-coverage 1000 Genomes approach, which generated whole-genome sequencing data of 179 individuals with different ancestry (YRI, CEU, and AS), is estimated to have relatively low power to detect singleton SNPs or rare variants ([@bib30]). Thus, sliding-window analysis and comparison with Sanger resequencing data also serve the purpose of testing the suitability of low-coverage data for large-scale identification of balancing selection targets. Therefore, we calculated *π* and the ratio of *θ*~W~ over human--chimpanzee divergence in sliding windows moving along *ZC3HAV1.* It should be noted that sliding-window analyses have an inherent multiple testing problem that is difficult to correct because of the nonindependence of windows. In order to partially account for this limitation, we applied the same procedure to 2,000 randomly selected human genes, and the distribution of *π* and *θ*~W~ per divergence was obtained for the corresponding windows. This allowed calculation of the 95th percentile and visualization of regions that exceed this threshold; nonetheless, these analyses should be regarded as mainly exploratory and descriptive.

Using the 1000 Genomes data for the three populations, peaks of both *π* and *θ*~W~ per divergence were observed for *ZC3HAV1* exons 10--12 and 13, the two regions we resequenced ([supplementary fig. S4](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). In both cases, nucleotide diversity exceeded the 95th percentile. Yet, contrary to our results based on Sanger resequencing, higher values of both diversity estimates were obtained for region 1. Further analyses indicated that, as expected, the 1000 Genomes Project detected more variants in region 1 than we did in our smaller sample ([supplementary table S6](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). The opposite situation occurred in region 2, where we detected a total of 24 variants compared with 13 in the low-coverage data. Inspection of these SNPs revealed that most of them (*n* = 8) have intermediate frequency in all populations we analyzed and are located within an AluSx element in the 3′ untranslated region of *ZC3HAV1* ([supplementary table S6](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Indeed, a large portion of "inaccessible sites" in the low-coverage 1000 Genomes data maps to repetitive sequences ([@bib30]); sliding-window analysis of *ZC3HAV1* after masking of transposable elements revealed a similar or higher nucleotide diversity in region 2 compared with region 1 ([supplementary fig. S5](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online).

In order to verify whether this report bias represents a general feature of low-coverage data, we calculated *θ*~W~ using both the NIEHS and the 1000 Genomes data for a large number of windows deriving from either unique or repetitive sequences (see Materials and Methods). In YRI, CEU, and AS, Kendall\'s correlation coefficient (τ) between *θ*~W~ estimates obtained using the two data sets was higher for unique compared with repetitive sequences (for unique and repetitive sequences, CEU: τ = 0.46 and 0.38; YRI: τ =0.55 and 0.48; and AS: τ = 0.69 and 0.60, all *P* values \< 0.001). Quantile--quantile plots of *θ*~W~ values calculated from the 1000 Genomes low-coverage data and from NIEHS Sanger resequencing experiments indicated that higher estimates of nucleotide diversity are obtained from the latter, and the discrepancy is stronger for transposable elements compared with unique regions ([supplementary fig. S6](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online).

We next used 1000 Genomes data to calculate *D*~T~, *F*\* and *D*\* for the two *ZC3HAV1* region we resequenced. These values were compared with those deriving from 2,000 windows (2.5 kb in size) randomly drawn from the same 2,000 genes used above. Given the results obtained above, SFS-based statistics were calculated for both repeat-masked and nonmasked windows. As expected, all statistics tended to display higher values compared with those calculated from our resequencing experiments. Using both masked and unmasked regions, *D*~T~ and *F*\* calculated for the *ZC3HAV1* region 2 showed values equal to or above than the 99th percentile, confirming the rejection of neutrality ([supplementary table S7](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). No significantly high value was observed for region 1 ([supplementary table S7](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online).

Association Analysis for Multiple Sclerosis
-------------------------------------------

In order to test the possibility that, in analogy to other antiviral response genes ([@bib58]; [@bib10]), variants in ZC3HAV1 affect the susceptibility to MS, we analyzed SNPs located in region 2 in two Italian case/control cohorts. In particular, the Thr851Ile polymorphism (rs3735007) was genotyped in 507 MS and 523 healthy controls (HC) from mainland Italy. A significant deviation from HWE with an excess of homozygotes was observed in cases but not in controls (*P* = 0.026 for MS subjects). [@bib88] have developed a test to verify whether deviations from HWE can be explained by an underlying genetic model for the trait being analyzed rather than by other effects. Using a *K*~p~ (prevalence of MS in the general population) of 0.0007 for Mainland Italy ([@bib63]), the best fitting of the genotypic proportions in cases and controls was obtained with a recessive model. The goodness-of-fit test was not significant (*χ*^2^ = 2.27, *P* = 0.32, df = 2) for this model, and the estimated *γ* (homozygote relative risk) was 1.38. These data indicate that a recessive model with only genetic effects adequately explains HWE deviation in the Italian sample. Comparison of genotype frequencies in MS and HC indicated a significant difference (Fisher\'s exact *P* value = 0.016, 2 df), and for a recessive model with CC homozygotes predisposed to disease, the odds ratio \[OR\] was 1.47 (95% confidence intervals \[CI\]: 1.08--1.99, *P* = 0.011) ([table 3](#tbl3){ref-type="table"}). In order to replicate this finding, we obtained the genotype distribution of rs1047129, which is in tight LD with rs3735007 (*r*^2^ = 0.87), from a case--control genome-wide association study for MS performed in a population of 4,416 individuals from Sardinia (2,270 patients and 2,146 controls). rs1047129 is located on the major branch leading to clade 2 (variant 24 in [fig. 3](#fig3){ref-type="fig"}), and its T allele is in phase with the rs3735007 C allele. No deviation from HWE was observed for rs1047129. As shown in [table 3](#tbl3){ref-type="table"}, the genotype frequency of this SNP significantly differed in cases and controls (for a recessive model with TT homozygotes predisposed to disease, OR = 1.18, 95% CI: 1.037--1.344, *P* = 0.011).

###### 

Association Analysis of *ZC3HAV1* Variants in Multiple Sclerosis.

                                       Genotype Counts                                  
  ----------- --- --- ---------------- ----------------- -------------- ------- ------- -------------------
  rs3735007   C   T   Mainland Italy   132/228/147       101/275/147    0.016   0.011   1.47 (1.08--1.99)
  rs1047129   T   C   Sardinia         746/1098/426      629/1100/417   0.037   0.011   1.18 (1.03--1.34)
  rs3735007   C   T   Belgium          182/401/236       96/205/128     0.91    0.73    1.05 (0.81--1.37)

Allele 1.

Allele 2.

Fisher\'s exact test *P* value for a genotypic model.

Fisher\'s exact test *P* value for a recessive model.

OR for a recessive model with 95% CI.

Finally, we analyzed rs3735007 in MS and HC individuals from Belgium. In this population, we observed no deviation from HWE and no difference in the genotype distribution of cases and controls ([table 3](#tbl3){ref-type="table"}).

Discussion
==========

Genes coding for protein products involved in both adaptive and innate immune responses have likely been subject to an extraordinary selective pressure during the evolutionary history of mammals. Although some of these genes have been targets of relatively recent selective events in human populations (reviewed in [@bib4]), other loci may have evolved in response to long-term pressures. In this latter situation, polymorphisms may be maintained in populations for a period of time, which is statistically inconsistent with neutrality and even survive speciation events ([@bib14]).

A large body of evidence suggests that long-standing balancing selection has shaped diversity at the human HLA class I and class II genes and maintained *trans*-specific polymorphisms at these loci ([@bib45]; [@bib48]; [@bib33]; [@bib14]). For HLA genes, natural selection is thought to promote diversity at the peptide-binding cleft of antigen presenting molecules and to be pathogen driven ([@bib62]). Outside the major histocompatibility complex (MHC), no human/chimpanzee *trans*-specific amino acid variant has been reported, and the scant descriptions of long-standing balancing selection in humans have involved innate immunity genes ([@bib11], [@bib9]). This testifies the extraordinary relevance of adaptive immunity for organism survival but suggests that searching for long-standing signatures of natural selection might contribute to the identification of non-HLA loci and variants with a prominent role in immune response. Our data suggest that the Thr851Ile variant in the PARP-like domain of ZC3HAV1 has been maintained as a *trans*-specific variant in human and chimpanzee populations. Several evidences support this conclusion and argue against the possibility that the polymorphism results from concurrent mutation in the two species. First, as calculated above, the probability that the variant represents an independent mutation event in the human and chimpanzee lineages is low and much more so when the presence of a second shared SNP (albeit involving a CpG dinucleotide) is accounted for. Therefore, at least one of the two shared polymorphisms is likely to have arisen before speciation. The lower mutability of rs3735007 compared with the CpG SNP and its potential functional significance (it accounts for the Thr851Ile variant) make it a better candidate as a selection target. Second, all tests supported the action of balancing selection on ZC3HAV1 region 2 in human populations. Third, using different methods, we estimated TMRCAs of the haplotype genealogy ranging from 4.36 to 6.12 myr. These are much deeper than expected under neutrality, although they display large variances and differ sensibly from one another. This is expected as relatively few segregating sites are used for time estimates, despite high local diversity. Several studies have provided different estimates for the human/chimpanzee lineage split (with ranges from 4 to 7 myr; [@bib32]; [@bib44]), again with wide confidence intervals. Therefore, although caution should be used when speculating on date estimates, the TMRCAs we obtained for *ZC3HAV1* exon 13 might be consistent with the Thr851Ile variant having arisen before human/chimpanzee lineage split. Finally, analysis of the chimpanzee sample also suggested the action of natural selection, as demonstrated by the higher nucleotide diversity observed in *ZC3HAV1.* The average estimates obtained for *θ*~W~ (0.054%) and *π* (0.056%) for putatively neutrally evolving regions are comparable to although slightly lower than previously reported data for *P.t. verus* populations both in intergenic and in genic regions ([@bib31]; [@bib91]; [@bib85], [@bib84]; [@bib17]). This discrepancy may be due to the relatively limited number of individuals we resequenced. Still, the values we calculated for *ZC3HAV1* are higher than those obtained for all other regions, suggesting the action of natural selection in the maintenance of diversity at this locus. Moreover, haplotype analysis indicated that, in analogy to the observation in humans, the *trans*-specific SNP separates the two major haplotype clades.

Despite its limitations, sliding-window analysis of ZC3HAV1 using the 1000 Genomes low-coverage whole-genome data also suggested that the balancing selection signature is located in the region surrounding exon 13 ([supplementary figs. S4 and S5](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). To our knowledge, low-coverage data have never been used for the detection of balancing selection signatures. Our comparison with Sanger resequencing experiments suggests that unequal coverage of repetitive elements ([@bib30]) may bias diversity estimates across the genome. Indeed, using a large number of gene windows resequenced by both the 1000 Genomes Project and by the NIEHS Program, we show that the presence of transposable elements biases nucleotide diversity estimates obtained through next generation sequencing approaches. Thus, large-scale efforts aimed at describing natural selection through the use of low-coverage data should be better performed after repeat masking.

It is worth noting that, despite having an extremely deep coalescent time, the *ZC3HAV1* region surrounding exon 13 displays high LD ([supplementary fig. S3](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online) and virtually no evidence of recombination (as also evident from the haplotype genealogy; [fig. 3](#fig3){ref-type="fig"}). This is partially explained by the region being short; as mentioned above, signatures of long-standing balancing selection are expected to have a limited genomic span (in the order of a few hundred bases), given that they are eroded over time by both mutation and recombination, as determined by both simulations and real-data analyses ([@bib89]; [@bib8]). Thus, the power to detect long-term balancing selection is higher in regions with low recombination rates ([@bib89]), as the one we describe herein. In particular, [@bib8] suggested that, in order to be detectable, long-standing balancing selection must involve at least two physically linked loci that are both selection targets (i.e., a balanced haplotype). This would allow accumulation of neutral variability over longer regions due to selection against most recombination events in the interval. Whether another variant in the region, in addition to Thr851Ile, represents a selection target remains to be evaluated, but this possibility might reconcile the strong LD we detected with the deep coalescence time of the haplotype genealogy.

The possible functional significance of the Thr851Ile variant is difficult to infer, as the role of the PARP-like domain itself is presently unknown. In order to evaluate the possible functional effect of the amino acid replacement, we applied several prediction algorithms. The GERP ([@bib18]) and Grantham scores ([@bib35]) (−6.1 and 89, respectively) indicated that the position is not highly conserved and that the substitution is moderately conservative. Application of the PolyPhen ([@bib76]), PolyPhen2 ([@bib2]), SIFT ([@bib57]), Panther ([@bib79]), and SNPs&GO ([@bib12]) algorithms suggested that the variant has relatively limited functional impact (not shown). Conversely, SNAP ([@bib7]) indicated the SNP to be nonneutral, although with very low reliability, and the use of MutPred ([@bib46]) yielded a relatively high general score (0.586) and a borderline probability (*P* = 0.054) that the variant might affect ubiquitination at a nearby Lysine residue (K849). Although potentially interesting given the known exploitation of the host\'s ubiquitin system for immune evasion, this result should be taken with caution as prediction of ubiquitination sites (using UbPRED, [@bib66] and CKSAAP_UbSite, [@bib15], not shown) yielded low scores for K849. Overall, a conservative interpretation of the results for prediction algorithms is that the SNP has no major effect on the function of ZC3HAV1. We consider that this finding is not in contrast with the hypothesis that rs3735007 represents the selection target; indeed, selection might have operated not by hampering or reducing protein function but rather by modifying its affinity or binding specificity for viral components, a possibility that is difficult to test by the use of available prediction algorithms. In fact, a previous analysis of the entire *ZC3HAV1* coding region indicated that the PARP-like domain has been a target of selection during primate evolution, as well, suggesting that it serves some important function for survival or reproduction ([@bib43]). In line with these considerations, it has been demonstrated that the long *ZC3HAV1* isoform containing the PARP-like domain has stronger activity against alphaviruses compared with the shorter form ([@bib43]). Therefore, a straightforward interpretation of our data envisages a situation where the *trans*-specific polymorphism affects either the specificity of viral recognition by *ZC3HAV1* or the binding of a viral inhibitor to *ZC3HAV1*, two alternatives that were previously proposed to account for the positive selection signature of this region in primates ([@bib43]). One interesting possibility is a genetic conflict between primate hosts and viral pathogens involving the *ZC3HAV1* PARP-like domain on one side and the viral macrodomains on the other. Macrodomains are conserved in several organisms and are generally referred to as X domains in the context of viral-encoded proteins ([@bib34]). Apart from alphaviruses, few other viruses, including coronaviruses and rubella, possess X domains ([@bib20]; [@bib56]). Cellular macrodomains have the ability of inhibiting PARPs through a direct interaction ([@bib59]), and a recent report identified three macrodomains encoded by the highly pathogenetic SARS-CoV ([@bib78]). The authors suggested that viral macrodomains might have evolved to counteract the antiviral activity of ZC3HAV1 ([@bib78]). Whether *ZC3HAV1* has any activity against coronaviruses and whether this occurs through the PARP-like domain remains to be elucidated. Nonetheless, these observations suggest that ZAP might display an antiviral activity that extends beyond alphaviruses and filoviruses and may include more common human pathogens, such as rubella and coronaviruses.

Although a specific causative agent has never been identified, several evidences suggest that viral infections may cause or at least contribute to the development of MS. MS is an autoimmune disease which results from the exposure of genetically predisposed individuals to environmental factors which, in turn, trigger a breakdown in T-cell tolerance to myelin antigens. In line with the possible involvement of viral agents in the pathogenesis of MS, a recent report indicated that a polymorphism which decreases the enzymatic activity of *OAS1*, an antiviral response gene, is associated with MS predisposition and disease severity ([@bib58]; [@bib10]). This concept is supported by the observation that a subset of human genes involved in the pathogenesis of MS have been targets of virus-driven selection ([@bib25]). Data herein indicate that, in two independent and genetically distinct populations from Italy, variants in *ZC3HAV1* confer a risk to develop MS. The reasons why this finding was not replicated in a Belgian sample remain to be elucidated and may derive either from insufficient statistical power of the study or from the interaction between *ZC3HAV1* polymorphisms with environmental factors. Such an interaction occurs between the hepatitis A virus (HAV) and polymorphisms in its receptor: HAV infection is protective against atopy only in subjects carrying a polymorphic 6-amino acid insertion in the *HAVCR1* mucin-like domain ([@bib50]). Indeed, gene-by-environment (GXE) interactions have been recently shown to represent a common attribute of complex diseases ([@bib68]). In the case of MS, the relevance of GXE interaction remains to be evaluated, but several epidemiological studies (reviewed in [@bib19]) indicate that diverse environmental risk factors modulate disease prevalence. Also, it is worth mentioning that rs3735007 is included in a relatively large LD block that partially covers the nearby *ZC3HAV1L* gene ([supplementary fig. S2](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online), putatively encoding an antiviral protein with still uncharacterized function. Thus, we cannot rule out the possibility that the association we detected with MS in the Italian cohorts is accounted for by a variant located in *ZC3HAV1L.* The probability is low that a nonsynonymous SNP in this latter gene is responsible, as the only one (rs17856272) displays very low frequency in CEU and limited LD (*r*^2^ = 0.038) with rs3735007. Still, other variants with regulatory function located within the LD block might account for the association with MS and need to be examined in further studies.

In summary, our data describe one of the first examples *trans*-specific coding SNP maintained by balancing selection and located outside the MHC and warrant further analyses on the role of this variant in MS susceptibility.

Supplementary Material
======================

###### 

Click here for additional data file.
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